
Gaudium IVF and Women Health's Rs 165-crore IPO closed on February 24, receiving strong investor interest with a 7.27 times overall subscription. Non-institutional and retail investors showed robust demand, subscribing 14.05 and 7.60 times respectively, while qualified institutional buyers subscribed 1.62 times. The IPO, priced at Rs 75-79 per share and valuing the company at Rs 575 crore, aims to fund expansion of IVF centres, debt repayment, and corporate purposes. The company reported FY25 revenue of Rs 70.72 crore and a profit after tax of Rs 19.13 crore. Brokerages recommend subscribing, citing growth prospects in India's fertility services sector. The shares are expected to debut on February 27 with a modest grey market premium indicating a positive listing.
Select a news story to see related coverage from other media outlets.